Agrium logo

ValueAct, Agrium In 'Very Good Two-Way Dialogue'

We found out last week that activist hedge fund ValueAct Capital had built up a large position Agrium Inc. (NYSE:AGU) (TSE:AGU), and based on recent comments from Agrium CEO Chuck Magro it sounds like the two sides are off to an amicable start and ValueAct isn’t making any big demands upfront.

“We’ve had very good two-way dialogue,” said Magro, reports Rod Nickel for Reuters. “So far, what they’re telling me is the reason they’ve invested in Agrium is they like the strategic plan.”

Agrium logo

Magro wouldn’t say if ValueAct wants a board seat

Magro wouldn’t comment on whether or not ValueAct is seeking a board seat, but we know that the fund’s normal approach is to ask for a single board seat (partly because it’s so hard for management to turn down such a mild request) and then send the person with the most knowledge of the business from their side to explain their ideas and influence board decisions over a longer period of time. That’s not to say ValueAct would never start a proxy fight, but this soft power, long-term approach to activism works better when the management has agreed to their having a seat at the table.

Agrium still up following ValueAct filing

Agrium Inc. (NYSE:AGU) (TSE:AGU) stock price shot up after the announcement that ValueAct had taken a position (and that it had been willing to pay in the mid $90s to do so), and it has only continued to appreciate in the last few days. Based on ValueAct’s reputation, and the lack of social media invective that often accompanies other activist funds campaigns, you could have guessed that it and Agrium were in talks, but it’s still important to get some confirmation from the CEO.

It’s still not clear what specifically ValueAct wants to accomplish by getting involved in Agrium Inc. (NYSE:AGU) (TSE:AGU), and we might not find out right away. If ValueAct likes Agrium’s strategic plan, then it probably won’t be looking to make and big, sudden changes. For investors thinking about ValueAct into the deal, it’s probably better to think of ValueAct’s presence (assuming they do end up with a board seat) as a tailwind to whatever valuation you already had for Agrium instead of a special event that will unlock value in the near term.


Saved Articles

The Life and Career of Charlie Munger

Charlie is more than just Warren Buffett’s friend and Berkshire Hathaway’s Vice Chairman – Buffett has actually credited him with redefining how he looks at investing. Now you can learn from Charlie firsthand via this incredible ebook and over a dozen other famous investor studies by signing up below:

  • Learn from the best and forever change your investing perspective
  • One incredible tidbit of knowledge after another in the page-turning masterpiece of a book
  • Discover the secrets to Charlie’s success and how to apply it to your investing
Never Miss A Story!
Subscribe to ValueWalk Newsletter. We respect your privacy.

Are you an intelligent investor?

ValueWalkPremium is a website and newsletter for smart investors like yourself. We focus on the latest hedge fund industry news much of which is not in the public domain and obtained via our sources.

We also have 10 years of resources on how to use this information to better your investment process.

Sign up for  today for only a few dollars a day and get a 3 day no obligation trial with a targeted 20% discount coupon code.

Cancel anytime during trial and you are never charged.

Limited time offer: For first 50 subscribers